Clinical Trial Update: The Evaluation Studies of Curative Effect of Fu-zheng-qu-zhuo Oral Liquid in Treatment of Ischemic Nephropathy [Phase 2, Phase 3]

View source ↗

Summary

An update on Phase 2 and Phase 3 studies evaluating Fu-zheng-qu-zhuo Oral Liquid for ischemic nephropathy caused by atherosclerotic renal artery stenosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Renal Artery Stenosis
• Ischemic Nephropathy

Drugs mentioned

• Fu-zheng-qu-zhuo Oral Liquid

Snippet

Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Conditions: Atherosclerotic Renal Artery Stenosis | Phase 2, Phase 3 | Status: UNKNOWN